Teton Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
TI
FWIA
Teton Advisors's ANIK Position: Q3 2022 in Review
Teton Advisors sold out of Anika Therapeutics (ANIK) in Q3 2022, closing a stake of 22,000 shares — an estimated $491K sold.
Teton Advisors first reported a position in ANIK in Q2 2018 and held it in 17 quarters. The position peaked at $1.63M in Q2 2019. 121 funds tracked by Wall St. Rank hold ANIK as of Q3 2022.
- Teton Advisors reported no remaining Anika Therapeutics position as of Q3 2022 after selling out during the quarter.
- Teton Advisors sold 22,000 Anika Therapeutics shares in Q3 2022, an estimated $491K.
- Teton Advisors first reported a position in Anika Therapeutics in Q2 2018 and held it in 17 quarters.
- Teton Advisors's Anika Therapeutics position peaked at $1.63M in Q2 2019.
- 121 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2022.
Based on Teton Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.